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Summary
Thirty-two Holstein transition cows were used to determine the effects of monensin (Rumen-
sin, Elanco Animal Health, Greenfield, IN; 400 mg/cow daily) on metabolism and feeding 
behavior. Cows were assigned randomly, based on calving date, to control or monensin treat-
ments (n = 16 per treatment) 21 days before their expected calving date, and cows remained 
on treatments through 21 days in milk. Feeding behavior and water intake data were collected 
daily. Blood samples were collected at 8 different time points during the experimental period. 
Monensin decreased mean and peak plasma ketone concentrations, and also decreased time 
between meals before and after calving. No effects of monensin supplementation were observed 
on milk production or other metabolic traits. Furthermore, we observed no treatment effects 
on disease incidence, although sample size was small for detecting such effects.
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Introduction
The weeks surrounding calving are a critical time in the life cycle of a dairy cow. During this 
period, cows make many metabolic adjustments to support the transition from pregnancy to 
lactation. Feed intake can be directly linked to a successful transition. Recent research indicates 
a beneficial effect of monensin on postpartum feed intake, but the mechanism responsible for 
improved intake is not clear. Research from feedlot cattle suggests dietary monensin could 
modulate intake patterns, thus reducing dramatic changes in rumen pH while cattle are adapt-
ing to a higher-energy diet.
Furthermore, in recent years, monensin has been used to help mitigate the effects of a transi-
tion-related negative energy balance, which traditionally has been attributed to its ability to 
promote the production of glucose precursors. However, investigators across the country have 
uncovered evidence suggesting that the beneficial effects of monensin actually may be indepen-
dent of changes in glucose production. 
The primary objectives of this study were to determine the effects of monensin on transition 
cow feeding behavior and metabolic parameters. The secondary objectives were to assess the ef-
fects of monensin on productivity and disease incidence of transition cows.
Experimental Procedures
Thirty-two Holstein transition cows were assigned to a control or treatment group 21 days 
before their expected calving date (16 cows per treatment). Cows remained on their respec-
tive treatments through 21 days postpartum. Treatment cows received monensin (Rumensin, 
Elanco Animal Health) as a top-dress at a rate of 400 mg/cow per day. Monensin was premixed 
into a ground corn carrier and 2 lb of the premix was top-dressed once daily to each treatment 
cow. The controls received no monensin in 2 lb of the same ground corn carrier for the duration 
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of the study. Diets were formulated to meet or exceed National Research Council requirements 
(Table 1). Cows were dried off approximately 45 days before expected calving date. Monensin 
was excluded from the far-off dry cow ration to help ensure that no cows entering the study 
were influenced by prior monensin exposure.
Management of Cows and Data Collection. Cows were allowed ad libitum access to the des-
ignated treatment rations by an electronic gating system, with one cow assigned per gate. After 
parturition, cows were moved into a tie-stall facility where they were housed for the remainder 
of the study. Dry cows were fed twice daily (8:00 a.m. and 3:30 p.m.) to accommodate the ca-
pacity of the feeding system used prepartum. Lactating cows were fed once daily (3:00 p.m.) to 
minimize the time during which feeding behavior could not be recorded.
Cows were milked 3 times daily in a milking parlor, and milk yield was recorded at each milk-
ing. Milk samples were collected during each milking beginning at 4 days in milk and continu-
ing through 21 days in milk. Body condition score (BCS; 1=thin and 5=fat) and body weight 
was measured 2 hours before feeding on days −21 and −7 relative to expected calving, and on 
days 1, 7, and 21 postpartum. Blood was collected 2 hours before feeding on these days, as well 
as on days -4, 4, and 14 relative to calving.
Postpartum cows (and prepartum cows with abnormalities) underwent a daily health inspec-
tion, including monitoring for urine ketones and rectal temperature. Health records were 
kept throughout the study to register disease incidence. If cows displayed a disorder, they were 
treated according to on-site standard operating procedures.
Results and Discussion
Feed Intake and Milk Production. Daily feed intake is shown in Figure 1A. As expected, 
average daily intake declined before calving and increased after calving in both treatments. Dry 
matter intake was not affected by treatment during the pre- or postpartum periods. This result 
was surprising because other transition cow research has shown monensin to have an effect on 
feed intake. 
Although intakes were similar, monensin supplementation decreased (P < 0.03) time between 
meals before calving and tended (P < 0.08) to decrease time between meals postpartum (Table 
2 and Figure 1B). These findings align with reports showing that inclusion of monensin in feed-
lot diets resulted in more consistent patterns of feed intake throughout the day. Even though 
the intermeal interval was shorter with monensin supplementation, the number of meals 
consumed per day and average meal duration did not differ between treatments. Meal sizes were 
similar overall (Table 2), but a treatment by day interaction was observed for postpartum meal 
size. In other words, monensin increased meal sizes on days 8, 15, 20, and 21 (Figure 1C), but 
not on other postpartum days. The small increase in meal frequency, coupled with similar to 
larger meal sizes, resulted in small, non-significant increases in dry matter intake for monensin-
supplemented cows during the postpartum period. As expected, intake was noticeably different 
pre- and postpartum; however, the dramatic decrease in meal duration (Table 2) for postpar-
tum cows compared with prepartum cows likely reflects differences in feeding behavior of cows 
in tie-stall vs. pen housing rather than a true stage of production effect. Previous studies have 
shown that cows in pen settings eat fewer, larger meals each day than cows housed in tie-stalls.
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Daily water consumption did not differ between treatments throughout the experimental pe-
riod (Table 2). Postpartum water intake started at approximately 20 gal/day, and, as expected, 
increased (P < 0.001) to 30 gal/day by day 21.
Cows receiving monensin tended (P < 0.09) to have smaller body weights on day 1 postpartum, 
but no other differences were observed between treatments for BCS or body weight (data not 
shown). On average, cows lost 0.6 BCS units (3.3 to 2.7) during the experiment. Milk produc-
tion (85.9 vs. 86.6 ± 3.7 lb/day for control and monensin, respectively; P = 0.92) and concen-
trations of fat, protein, lactose, and solids-non-fat did not differ between dietary treatments, but 
milk urea nitrogen (MUN) was greater (P < 0.02) for monensin-supplemented cows (11.8 vs. 
10.4 ± 0.42 mg/dL). We have no clear explanation for the observed effect on MUN; it could 
be related to impaired liver function in the control or a result of monensin’s ruminal protein 
sparing effect, allowing more escape protein to reach the small intestine. A simpler explanation, 
however, is to consider that monensin-supplemented cows consumed, on average, an additional 
0.51 lb/day of protein, with no increase in milk protein yield. If metabolizable protein supply 
did not limit milk protein yield, then the increase in MUN for the monensin treatment was an 
expected response to increased protein intake.
Metabolic and Endocrine Changes. Plasma non-esterified fatty acids (NEFA), ketones, glu-
cose, and insulin concentrations are displayed in Figure 2. As expected, plasma NEFA con-
centrations increased dramatically before expected calving, to a peak of 878 ± 80 µM on day 
1 postpartum (Figure 2A; P < 0.001). Monensin supplementation did not significantly alter 
NEFA concentrations throughout the study. This was somewhat unexpected, because previous 
research demonstrated that monensin could decrease NEFA concentration.
Monensin treatment decreased (P < 0.05) plasma ketone β-hydroxybutyrate concentration 
during the entire study (734 vs. 616 ± 40.9 µM). The effect of treatment day (P < 0.001) and a 
treatment by day interaction (P < 0.01; Figure 2B) were also significant. Most notably, monen-
sin decreased (P < 0.01) plasma β-hydroxybutyrate on day 4 postpartum (777 vs. 1077 ± 71 
µM). The effect on β-hydroxybutyrate is not surprising given that many other reports have dem-
onstrated similar decreases in β-hydroxybutyrate. Smaller β-hydroxybutyrate concentrations in 
response to monensin are likely a result of more complete fatty acid oxidation in the liver.
Plasma glucose concentrations decreased after parturition in both groups (P < 0.001), but 
monensin did not affect pre- or postpartum plasma glucose concentrations (Figure 2C). Previ-
ous work indicates that monensin can increase plasma glucose concentration of transition cows, 
but increases were not consistently reported. Furthermore, because monensin does not always 
affect ruminal propionate production in transition cows, we would not expect substrate-driven 
changes in liver glucose production, although monensin could also alter gluconeogenic enzyme 
capacity.
Overall, monensin treatment did not affect plasma insulin concentration (Figure 2D); however, 
a tendency for higher plasma insulin concentration in monensin-fed cows was detected on day 7 
postpartum (P < 0.08). Interestingly, 5 other studies failed to observe an effect of monensin on 
insulin concentration in transition cows, making increased insulin concentration unlikely to be 
a primary mechanism by which monensin alters transition cow metabolism.
Management and Health. Incidence of health disorders is shown in Table 3. No differences 
were detected between treatments. Because only 32 cows were used for this study, detecting dif-
6Nutrition and Feeding
ferences in disease incidence is unlikely. A more powerful assessment of the effects of monensin 
on cow health is the meta-analysis of 16 different studies conducted by scientists at the Univer-
sity of Guelph. Overall, monensin significantly decreased the relative risk of ketosis, displaced 
abomasum, and mastitis. The β-hydroxybutyrate response observed in our study is consistent 
with the numbers reported in that meta-analysis. Therefore, monensin likely reduces the risk of 
diseases such as ketosis and displaced abomasa, although our study lacked statistical power to 
detect these differences.
In this first report of monensin’s effects on feeding behavior, monensin increased meal 
frequency. Consistent with previous results, monensin significantly decreased plasma 
β-hydroxybutyrate concentrations in postpartum cows, but did not alter concentrations of 
plasma NEFA, glucose, or insulin during early lactation. Despite the observed beneficial effects 
on metabolism, no significant effects on milk production or disease incidence were detected.
Table 1. Ingredient and nutrient composition of diets
Item Prepartum Postpartum
Ingredient, % of dry matter
Corn silage 30.3 34.0
WCGF1 19.6 21.5
Prairie hay 39.7 …
Alfalfa hay … 16.6
Cottonseed … 6.7
Corn grain2 6.5 12.4
Soybean meal 48 4.1 …
Expeller soybean meal … 7.1
Micronutrient premix3,4 0.3 2.8
Nutrient, % of dry matter
Dry matter, % as-fed 57.2 54.2
Crude protein 13.1 17.3
Acid detergent fiber 28.4 19.7
Neutral detergent fiber 49.9 36.0
Nonfiber carbohydrates 35.5 38.0
Ether extract 3.4 5.0
Ash 6.9 8.8
NEL, Mcal/lb
5 0.72 0.76
1 Wet corn gluten feed (Sweet Bran, Cargill, Inc., Blair, NE).
2 A portion of the daily corn grain (2 lb/cow) served as the top-dress carrier for 400 mg monensin (Rumensin, Elanco Animal 
Health, Greenfield, IN) for supplemented cows. The same amount of corn alone was top-dressed for control cows.
3 Prepartum premix consisted of 42.6% vitamin E premix, 11.9% Se premix, 11.6% trace mineral salt, 10.8% limestone, 9.71% 
vitamin A premix, 6.47% 4-plex, 4.31% vitamin D premix, 2.17% magnesium oxide, and 0.53% ethylenediamine dihydroio-
dide.
4 Postpartum premix consisted of 48.4% limestone, 27.3% sodium bicarbonate, 12.6% trace mineral salt, 6.04% magnesium 
oxide, 2.33% 4-plex, 1.51% Se premix, 1.16% vitamin E premix, 0.46% vitamin A premix, 0.21% vitamin D premix, and 
0.03% ethylenediamine dihydroiodide.
5 Estimated according to NRC (2001). Nutrient Requirements of Dairy Cattle, 7th rev. ed., National Research Council. Natl. 
Acad. Sci., Washington, DC.
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Table 2. Feed and water intake and feeding behavior during the transition period
Item Control Monensin SEM P-value
Prepartum water intake, gal/day 5.4 5.0 0.4 0.48
Prepartum dry matter (DM) intake, lb/day 30.6 31.1 1.3 0.83
Intermeal interval, min. 143 126 5.0 0.03
Meal frequency, meals/day 7.57 8.05 0.36 0.35
Meal size, lb DM 4.08 4.08 0.26 0.99
Meal length, min 43.4 42.9 2.3 0.88
Postpartum water intake, gal/day 26.8 26.8 2.7 0.99
Postpartum DM intake, lb/day 40.6 43.7 0.7 0.14
Intermeal interval, min. 88.8 81.4 2.9 0.08
Meal frequency, meals/day 13.7 14.8 0.5 0.12
Meal size1, lb DM 3.04 3.24 0.13 0.29
Meal length, min. 14.1 14.5 0.6 0.65
1 Treatment by day interaction (P < 0.02).
Table 3. Incidence of health disorders during the experimental period
Disorder1 Control Monensin
Retaind placenta 0 1
Body temperature (fever) > 103°F 5 7
Ketosis 5 3
Hypocalcemia 2 0
Metritis 1 1
Mastitis 7 5
Displaced abomasum 2 1
Other digestive disorder 4 3
One or more disorders 12 11
Dystocia2 3 5
1 No differences were detected between treatment groups using Fisher’s exact test.
2 Dystocia was defined as a calving difficulty score > 1.
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Figure 1. Dry matter intake (A), intermeal interval (B), and meal size (C) during the experimental 
period. 
A. There was an effect (P < 0.001) of pre- and postpartum day (prepartum SEM = 1.94, postpartum 
SEM = 1.92). B. Monensin shortened (P < 0.03) prepartum intermeal interval and tended (P = 0.08) to 
shorten postpartum intermeal interval. An effect (P < 0.001) of postpartum day was detected (prepar-
tum SEM = 10.6, postpartum SEM = 4.77;  †P < 0.10; *P < 0.05). C. A postpartum treatment by day 
interaction was detected (P < 0.02; prepartum SEM = 0.4, postpartum SEM = 0.2).
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Figure 2. Plasma concentrations of nonesterified fatty acids (A), beta-hydroxybutyrate (B), glucose 
(C), and insulin (D) during the experimental period.
A. No treatment effects were detected, but there was a day effect (P < 0.001; SEM = 84.9). B. A treat-
ment by day interaction (P < 0.01) was detected (SEM = 73.6; *P < 0.05). C. No treatment effects were 
detected — only a day effect (P < 0.001; SEM = 2.38). D. Significant effects of day (P < 0.001) and day 
by treatment interaction (P < 0.05) were detected. Cows receiving monensin tended (P < 0.10) to have 
greater plasma insulin concentrations on day 7 postpartum. SEM are shown in D (†P < 0.10).
